AAAAAA
Results: 1-25/43
Authors:
MIMOZ O
BINTER V
JACOLOT A
EDOUARD A
TOD M
PETITJEAN O
SAMII K
Citation: O. Mimoz et al., PHARMACOKINETICS AND ABSOLUTE BIOAVAILABILTY OF CIPROFLOXACIN ADMINISTERED THROUGH A NASOGASTRIC TUBE WITH CONTINUOUS ENTERAL FEEDING TO CRITICALLY ILL PATIENTS, Intensive care medicine, 24(10), 1998, pp. 1047-1051
Authors:
NICOLAS P
TOD M
PADOIN C
PETITJEAN O
Citation: P. Nicolas et al., CLINICAL PHARMACOKINETICS OF DIACEREIN, Clinical pharmacokinetics, 35(5), 1998, pp. 347-359
Authors:
MIMOZ O
JACOLOT A
PADOIN C
TOD M
SAMII K
PETITJEAN O
Citation: O. Mimoz et al., CEFEPIME AND AMIKACIN SYNERGY IN-VITRO AND IN-VIVO AGAINST A CEFTAZIDIME-RESISTANT STRAIN OF ENTEROBACTER-CLOACAE, Journal of antimicrobial chemotherapy, 41(3), 1998, pp. 367-372
Authors:
PADOIN C
TOD M
PERRET G
PETITJEAN O
Citation: C. Padoin et al., ANALYSIS OF THE PHARMACOKINETIC INTERACTION BETWEEN CEPHALEXIN AND QUINAPRIL BY A NONLINEAR MIXED-EFFECT MODEL, Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1463-1469
Authors:
TOD M
LORTHOLARY O
SEYTRE D
SEMAOUN R
UZZAN B
GUILLEVIN L
CASASSUS P
PETITJEAN O
Citation: M. Tod et al., POPULATION PHARMACOKINETIC STUDY OF AMIKACIN ADMINISTERED ONCE OR TWICE-DAILY TO FEBRILE, SEVERELY NEUTROPENIC ADULTS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 849-856
Authors:
NOUAILLEDEGORCE B
VEAU C
DAUTREY S
TOD M
LAOUARI D
CARBON C
FARINOTTI R
Citation: B. Nouailledegorce et al., INFLUENCE OF RENAL-FAILURE ON CIPROFLOXACIN PHARMACOKINETICS IN RATS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 289-292
Authors:
TOD M
PETITJEAN O
LORTHOLARY O
Citation: M. Tod et al., THERAPEUTIC MONITORING OF GLYCOPEPTIDES - WHY AND HOW, Medecine et maladies infectieuses, 27, 1997, pp. 954-957
Authors:
LORTHOLARY O
TOD M
DURANDGASSELIN B
GUILLEVIN L
PETITJEAN O
CASASSUS P
Citation: O. Lortholary et al., USING GLYCOPEPTIDES IN FEBRILE NEUTROPENI C ADULTS, Medecine et maladies infectieuses, 27, 1997, pp. 979-983
Authors:
MIMOZ O
JACOLOT A
PADOIN C
CAILLON J
LOUCHAHI K
TOD M
SAMII K
PETITJEAN O
Citation: O. Mimoz et al., CEFEPIME AND AMIKACIN SYNERGY AGAINST A CEFOTAXIME-SUSCEPTIBLE STRAINOF ENTEROBACTER-CLOACAE IN-VITRO AND IN-VIVO, Journal of antimicrobial chemotherapy, 39(3), 1997, pp. 363-369
Authors:
TOD M
ALET P
LORTHOLARY O
PETITJEAN O
Citation: M. Tod et al., IMPLEMENTATION AND EVALUATION OF A STOCHASTIC-CONTROL STRATEGY FOR INDIVIDUALIZING TEICOPLANIN DOSAGE REGIMEN, Journal of pharmacokinetics and biopharmaceutics, 25(6), 1997, pp. 695-712
Authors:
TOD M
ROCCHISANI JM
Citation: M. Tod et Jm. Rocchisani, COMPARISON OF ED, EID, AND API CRITERIA FOR THE ROBUST OPTIMIZATION OF SAMPLING TIMES IN PHARMACOKINETICS, Journal of pharmacokinetics and biopharmaceutics, 25(4), 1997, pp. 515-537
Authors:
LAROCHE L
GALLAIS V
LEON A
BAUDELOT J
TOD M
Citation: L. Laroche et al., EXTRACORPOREAL PHOTOCHEMOTHERAPY ASSOCIATED WITH ADJUVANT TREATMENT IN SEZARY-SYNDROME, Journal of investigative dermatology, 109(3), 1997, pp. 497-497
Authors:
DURANDGASSELIN B
LORTHOLARY O
TOD M
GUILLEVIN L
CASASSUS P
Citation: B. Durandgasselin et al., EFFICACY OF TEICOPLANIN IN STAPHYLOCOCCUS-AUREUS CATHETER-RELATED TRICUSPID ENDOCARDITIS DURING SEVERE NEUTROPENIA, Annales de medecine interne, 148(7), 1997, pp. 502-503
Authors:
TOD M
ROCCHISANI JM
Citation: M. Tod et Jm. Rocchisani, IMPLEMENTATION OF OSPOP, AN ALGORITHM FOR THE ESTIMATION OF OPTIMAL SAMPLING TIMES IN PHARMACOKINETICS BY THE ED, EID AND API CRITERIA, Computer methods and programs in biomedicine, 50(1), 1996, pp. 13-22
Authors:
JACOLOT A
TOD M
HEUDES AM
PETITJEAN O
LAROCHE L
Citation: A. Jacolot et al., MONITORING OF 8-METHOXYPSORALEN DURING EXTRACORPOREAL PHOTOCHEMOTHERAPY - EVIDENCE FOR A FIRST-DOSE EFFECT, Therapeutic drug monitoring, 18(3), 1996, pp. 234-239
Authors:
LORTHOLARY O
TOD M
RIZZO N
PADOIN C
BIARD O
CASASSUS P
GUILLEVIN L
PETITJEAN O
Citation: O. Lortholary et al., POPULATION PHARMACOKINETIC STUDY OF TEICOPLANIN IN SEVERELY NEUTROPENIC PATIENTS, Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1242-1247
Authors:
JACOLOT A
TOD M
PETITJEAN O
Citation: A. Jacolot et al., PHARMACOKINETIC INTERACTION BETWEEN CEFDINIR AND 2 ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN RATS, Antimicrobial agents and chemotherapy, 40(4), 1996, pp. 979-982
Authors:
TOD M
PADOIN C
MINOZZI C
COUGNARD J
PETITJEAN O
Citation: M. Tod et al., POPULATION PHARMACOKINETIC STUDY OF ISEPAMICIN WITH INTENSIVE-CARE UNIT PATIENTS, Antimicrobial agents and chemotherapy, 40(4), 1996, pp. 983-987
Authors:
MIMOZ O
JACOLOT A
PADOIN C
QUILLARD J
TOD M
LOUCHAHI K
SAMII K
PETITJEAN O
Citation: O. Mimoz et al., INFLUENCE OF EXPERIMENTAL RAT MODEL OF MULTIPLE ORGAN DYSFUNCTION ON CEFEPIME AND AMIKACIN PHARMACOKINETICS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 819-821
Authors:
LOUCHAHI K
TOD M
BONNARDEL P
PETITJEAN O
Citation: K. Louchahi et al., DETERMINATION OF PIRACETAM IN HUMAN PLASMA AND URINE BY LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 663(2), 1995, pp. 385-389
Authors:
TAMISIERKAROLAK SL
TOD M
BONNARDEL P
CZOK M
CARDOT P
Citation: Sl. Tamisierkarolak et al., DAILY VALIDATION PROCEDURE OF CHROMATOGRAPHIC ASSAY USING GAUSSOEXPONENTIAL MODELING, Journal of pharmaceutical and biomedical analysis, 13(8), 1995, pp. 959-970
Authors:
PETITJEAN O
TOD M
LOUCHAHI K
Citation: O. Petitjean et al., INFLUENCE OF METHODOLOGICAL ASPECTS ON TISSUE DRUG CONCENTRATION ESTIMATION, Journal of pharmaceutical and biomedical analysis, 13(7), 1995, pp. 817-822
Authors:
PETITJEAN O
JACOLOT A
TOD M
Citation: O. Petitjean et al., SYSTEMIC ANTIFUNGAL AZOLES PHARMACOLOGY, Medecine et maladies infectieuses, 25(BIS), 1995, pp. 14-26
Authors:
PETITJEAN O
JACOLOT A
TOD M
Citation: O. Petitjean et al., SYSTEMIC ANTIFUNGAL AZOLES PHARMACOLOGY, Medecine et maladies infectieuses, 25, 1995, pp. 14-26
Authors:
TOD M
POBEL C
LEGROS V
LOUCHAHI K
PETITJEAN O
BRION N
GARCIAMACE JL
Citation: M. Tod et al., A POPULATION PHARMACOKINETIC STUDY OF ALMINOPROFEN PENETRATION INTO SYNOVIAL-FLUID, Biopharmaceutics & drug disposition, 16(8), 1995, pp. 627-634